Signadori Bio
signadoribio.com
Actively hiring
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1–2
French register · Dec 2024
Backers
1
Sofinnova Partners
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 23
Increased its share capital $8.7k · BODACC
Jul 11, 2025
Increased its share capital $5.5k · BODACC
May 23, 2025
Renamed SIGNADORI BIO · BODACC
Apr 2, 2025
Increased its share capital $2.3k · BODACC
Apr 25, 2024
Founded per the company register
Registers and programsofficial lists and records that name the company
| Legal entity | SIGNADORI BIO | recherche-entreprises |
| Registered | 25 Apr 2024 |
Founders and leadersfrom filings, registers and the company's site
Selwyn HoPrésident de SAScompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Sofinnova Partners Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.
ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune…
Developing scalable in-vivo genomic medicine for blood disorders.
Creating next generation immunotherapy treatments for cancer and autoimmune disease.
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
People
Selwyn Ho
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Paris
France
HQ